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Point-of-care (POC) diagnostics describes a step in the medical treatment process where drugs can be 
monitored in a patient’s body on-site and in a timely fashion. Mass spectrometry (MS) can provide a 
quick, efficient, and highly accurate method of analysis of patient biofluids and tissues. Developing 
methods to bring this diagnostic mechanism to hospitals and clinics has the potential to improve patient 
care through, for example, personalized medicine. Our goal was to develop a way to effectively 
introduce internal standard (IS), a necessary chemical for the analytical process, to low-volume biofluid 
samples. Additionally, the effective direct quantitation of biomarkers with MS was demonstrated using a 
rat model of nicotine metabolism and the detection of 3-HPMA in urine. By pre-coating silica glass 
capillary tubes with a fixed volume with IS, biological samples, such as blood, can be obtained in the 
tube through capillary action and mixed with the IS before deposition for analysis. This method was 
applied to several different drugs and they were analyzed using a triple quadrupole mass spectrometer. 
It was optimized for the detection of the metabolite cotinine through a study of solvents and elution 
processes. Additionally, cotinine was quantified in rat’s blood using this method and the acrolein 
metabolite 3-HPMA was quantified in urine. Additional work is needed to expand this method for the 
rapid detection of other biomarkers. In the future, this can contribute to the expanded use of MS in 
clinical care and improved POC diagnostics. 
